Track record
Michelle Doig
An officer, director or large holder of 3 blank-check companies. Every role below was declared by Michelle Doig in an SEC ownership filing.
Vehicles
3
Still live
0
Closed a deal
2 of 3
Capital involved
$479M
Every vehicle, newest first
- BridgeBio Oncology Therapeutics, Inc.BBOT · Director · IPO Feb 13, 2024$197MCompleted
- Omega Alpha SPAC— · President · IPO Jan 8, 2021$139MLiquidated
- Nuvation Bio Inc.NUVB · Director · IPO Jul 2, 2020$144MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1832320. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.